The Cboe SPX options license has been extended for 25 years, preserving Cboe’s exclusive right to list S&P 500 index options through 2051.
Cboe Global Markets (CBOE: CBOE) and S&P Dow Jones Indices, a division of S&P Global (NYSE: SPGI), said the arrangement may also support new products beyond conventional index derivatives, including tokenized options contracts.
Cboe SPX Options License Protects a Core Franchise
The extension covers Cboe’s SPX options, which allow investors to manage broad U.S. equity exposure, according to the companies’ official joint announcement. The partnership began with the launch of the product in 1983.
SPX options recorded 970.6 million contracts in 2025, with average daily volume of 3.9 million. Daily activity increased 25% from the previous year and marked a fourth consecutive annual volume record.
The agreement provides long-term certainty over the index rights supporting that activity. Cboe and S&P did not disclose the total value of royalty payments or other commercial consideration in the announcement.
Licensing certainty matters because the index underpins one of the exchange’s highest-volume product families.
New Royalty Terms Begin in 2027
Cboe said the extension will not change its 2026 royalty-fee terms. Updated pricing starts in 2027, and management estimates the reset will have only a minimal effect on next year’s net-revenue growth after considering volume, pricing and business execution.
That assessment is a company forecast rather than a disclosed dollar estimate. Cboe added that royalty adjustments after the 2027 reset will be smaller, but did not provide a full schedule.
Potential tokenized products remain an area for collaboration, not a completed launch. Any such contract would still require product development, regulatory compliance and sufficient market demand before contributing revenue.
Cboe plans to provide more specific guidance for 2027 organic net-revenue growth with its fourth-quarter results in February. That disclosure should give investors a clearer basis for measuring the renewed license’s cost against continued SPX and VIX volume growth.
